Home/Pipeline/Target Discovery & Validation Platform

Target Discovery & Validation Platform

Various diseases

N/AActive

Key Facts

Indication
Various diseases
Phase
N/A
Status
Active
Company

About Paradigm4

Paradigm4 is a private, U.S.-based company offering a full-stack computational platform for large-scale biological data analytics, with roots in technology incubated at MIT. The company serves global life science firms, providing the infrastructure to manage and derive insights from massive, complex datasets like those from biobanks and genomic studies. Its business model is a hybrid of a technology platform and tech-enabled services, generating revenue through its solutions. Paradigm4's key differentiator is its high-performance data management system, which aims to reduce computational costs and complexity for its clients.

View full company profile

Other Various diseases Drugs

DrugCompanyPhase
Internal Biomarker Discovery ResearchMZ BiolabsResearch
New Target BiologyBiovistaService
Biomarker Research ServicesPolyQuantDiscovery/Validation